Stem cell-derived extracellular vesicles in the therapeutic intervention of Alzheimer’s Disease, Parkinson’s Disease, and stroke

6Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

With the increase in the aging population, the occurrence of neurological disorders is rising. Recently, stem cell therapy has garnered attention due to its convenient sourcing, minimal invasiveness, and capacity for directed differentiation. However, there are some disadvantages, such as poor quality control, safety assessments, and ethical and logistical issues. Consequently, scientists have started to shift their attention from stem cells to extracellular vesicles due to their similar structures and properties. Beyond these parallels, extracellular vesicles can enhance biocompatibility, facilitate easy traversal of barriers, and minimize side effects. Furthermore, stem cell-derived extracellular vesicles can be engineered to load drugs and modify surfaces to enhance treatment outcomes. In this review, we summarize the functions of native stem cell-derived extracellular vesicles, subsequently review the strategies for the engineering of stem cell-derived extracellular vesicles and their applications in Alzheimer’s disease, Parkinson’s disease, and stroke, and discuss the challenges and solutions associated with the clinical translation of stem cell-derived extracellular vesicles.

Cite

CITATION STYLE

APA

Zhou, W., Wang, X., Dong, Y., Gao, P., Zhao, X., Wang, M., … An, W. (2024). Stem cell-derived extracellular vesicles in the therapeutic intervention of Alzheimer’s Disease, Parkinson’s Disease, and stroke. Theranostics. Ivyspring International Publisher. https://doi.org/10.7150/thno.95953

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free